Clinical Trials
3 trialsNCT05117242 2026-04-30
Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer
Genmab
Phase 2 Active not recruiting
NCT04621188 2025-09-24
Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)
Intergroupe Francophone de Cancerologie Thoracique
Phase 2 Active not recruiting
NCT04951583 2024-08-07
FMT-LUMINATE
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 2 Active not recruiting